Results 121 to 130 of about 464,611 (330)
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai+5 more
wiley +1 more source
ABSTRACT Background Crohn's disease (CD) is an incurable inflammatory bowel disease that can lead to a variety of complications and requires lifelong treatment. However, the diagnosis and management of Crohn's disease exhibit high rates of misdiagnosis and missed diagnoses, along with significant variability, among primary care facilities and novice ...
Qiuyuan Liu+16 more
wiley +1 more source
THEORY AND PRACTICE IN THE TREATMENT OF GLAUCOMA. [PDF]
John Herbert Parsons
openalex +1 more source
Abstract Background This study aimed to compare the effects of placing an endotracheal tube (ETT) versus a V‐gel airway device on intraocular pressure (IOP), heart rate (HR), mean arterial pressure (MAP) and peripheral oxygen saturation (SpO2) in anaesthetised cats.
Mehmet Nur Cetin+5 more
wiley +1 more source
The device that will be most useful to assess the angles in the next 10 years will be…
Edgar U. Leuenberger, MD+2 more
doaj
Correlation of optic nerve hemoglobin levels with structural and functional parameters in glaucoma
Glaucoma is a chronic and progressive eye disease that leads to irreversible damage to the optic nerve and retinal nerve fiber layer, resulting in visual field loss.
Gustavo Coelho Caiado+6 more
doaj +1 more source
THE VALUE OF EXCISION OF THE SUPERIOR CERVICAL SYMPATHETIC GANGLION IN GLAUCOMA. [PDF]
George F. Suker
openalex +1 more source
Our findings demonstrate that NAD+ metabolism dysregulation contributes to elevated intraocular pressure in glaucoma. Supplementation with NAD+ precursors reduces IOP by alleviating oxidative stress, cellular senescence, and extracellular matrix deposition.
Youjia Zhang+10 more
wiley +1 more source
Brinzolamide is a widely used treatment for glaucoma, but its effectiveness relies on at least twice-daily dosing, which can be challenging for patient adherence.
Jiahao Xu+6 more
doaj +1 more source